/
Oral administration of a 2-aminopyrimidine robenidine analogue (NCL195) significantly reduces Staphylococcus aureus infection and reduces Escherichia coli infection in combination with sub-inhibitory colistin concentrations in a bioluminescent mouse model
- Nguyen, Hang Thi, Venter, Henrietta, Woolford, Lucy, Young, Kelly A., Mccluskey, Adam, Garg, Sanjay, Sapula, Sylvia S., Page, Stephen W., Ogunniyi, Abiodun David, Trott, Darren J.
In vitro synergistic activity of NCL195 in combination with colistin against Gram-negative bacterial pathogens
- Nguyen, Hang Thi, Venter, Henrietta, Veltman, Tania, Williams, Ruth, O'Donovan, Lisa Anne, Russell, Cecilia C., McCluskey, Adam, Page, Stephen W., Ogunniyi, Abiodun David, Trott, Darren J.
In vitro antimicrobial activity of Robenidine, Ethylenediaminetetraacetic acid and Polymyxin B Nonapeptide against important human and veterinary pathogens
- Khazandi, Manouchehr, Pi, Hongfei, Chan, Wei Yee, Ogunniyi, Abiodun David, Sim, Jowenna Xiao Feng, Venter, Henrietta, Garg, Sanjay, Page, Stephen W., Hill, Peter B., McCluskey, Adam, Trott, Darren J.
Are you sure you would like to clear your session, including search history and login status?